iifl-logo

Natco Pharma Ltd Share Price Live

884.45
(1.53%)
Jun 27, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open875
  • Day's High905.95
  • 52 Wk High1,639
  • Prev. Close871.15
  • Day's Low866
  • 52 Wk Low 726.8
  • Turnover (lac)10,021.41
  • P/E8.55
  • Face Value2
  • Book Value415.54
  • EPS103.31
  • Mkt. Cap (Cr.)15,841.37
  • Div. Yield0.68
View All Historical Data
No Records Found

Natco Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

875

Prev. Close

871.15

Turnover(Lac.)

10,021.41

Day's High

905.95

Day's Low

866

52 Week's High

1,639

52 Week's Low

726.8

Book Value

415.54

Face Value

2

Mkt Cap (₹ Cr.)

15,841.37

P/E

8.55

EPS

103.31

Divi. Yield

0.68

Natco Pharma Ltd Corporate Action

12 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 Aug 2024

12:00 AM

AGM

Announcement Date: 12 Aug, 2024

arrow

12 Feb 2025

12:00 AM

Dividend

Dividend Amount: 1.5

Record Date: 18 Feb, 2025

arrow

Natco Pharma Ltd NEWS AND UPDATE

NATCO Pharma receives 7 observations from USFDA
20 Jun 2025|12:25 PM

In a statement, NATCO Pharma stated it is confident of addressing all the observations within the stated time frame.

Read More
Top Stocks for Today - 20th June 2025
20 Jun 2025|06:07 AM

Here are some of the stocks that may see significant price movement today: United Spirits, Biocon, NATCO Pharma, etc.

Read More
Natco Pharma Q4 Net Profit Rises 5% YoY to ₹406 Crore
30 May 2025|12:15 AM

Quarterly revenue came in at ₹1,287.3 crore, a 16% YoY increase from ₹1,110.3 crore in Q4 FY24, led by robust performance in key segments.

Read More
Natco Pharma Gets USFDA Approval for Bosentan 32mg Tablets
12 Feb 2025|11:14 AM

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Read More
Natco Pharma Sells Telangana Land for ₹115.57 Crore
1 Dec 2024|07:16 PM

The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Natco Pharma Ltd SHAREHOLDING SNAPSHOT

28 Jun, 2025|02:24 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.41%

Foreign: 0.41%

Indian: 49.14%

Non-Promoter- 23.14%

Institutions: 23.14%

Non-Institutions: 27.28%

Custodian: 0.00%

Share Price

Natco Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

35.8

36.5

36.5

36.5

Preference Capital

0

0

0

0

Reserves

5,556.5

4,665.5

4,155.4

4,054.6

Net Worth

5,592.3

4,702

4,191.9

4,091.1

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

1,653.5

1,790.2

2,091.3

1,958

yoy growth (%)

-7.63

-14.39

6.8

84.85

Raw materials

-500

-397

-388.5

-572.8

As % of sales

30.23

22.17

18.57

29.25

Employee costs

-380

-356.1

-312.2

-232.1

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

392.2

583.1

887.6

634.1

Depreciation

-115.2

-98.1

-65.5

-53.6

Tax paid

-82.7

-108.6

-189.4

-139.3

Working capital

-24.9

273.2

977.8

236.8

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-7.63

-14.39

6.8

84.85

Op profit growth

-27.75

-37.74

34.16

146.52

EBIT growth

-33.16

-33.09

38.47

167.7

Net profit growth

-34.77

-32.03

41.1

180.33

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

4,429.5

3,998.8

2,707.1

1,944.8

2,052.1

Excise Duty

0

0

0

0

0

Net Sales

4,429.5

3,998.8

2,707.1

1,944.8

2,052.1

Other Operating Income

0

0

0

0

0

Other Income

354.5

128.1

104.6

99

103.6

Natco Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,669.8

93.524,00,520.992,000.460.967,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,616

79.481,75,574.286670.452,536561.08

Cipla Ltd

CIPLA

1,513.8

25.391,22,1861,485.41.064,254.47397.41

Dr Reddys Laboratories Ltd

DRREDDY

1,321.5

20.611,10,263.531,200.70.615,546.3345.76

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,222.5

57.291,09,167.444740.992,385224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Natco Pharma Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

V C Nannapaneni

Vice Chairman & CEO

Rajeev Nannapaneni

Vice President & Director

PSRK Prasad

President & Director

D Linga Rao

Vice President & Director

Pavan Bhat

Company Sec. & Compli. Officer

Venkat Ramesh

Independent Director

A D Murthy Chavali

Independent Director

B. Lakshminarayana

Independent Director

Kantipudi Suma

Independent Director

Nitin Jain

Independent Director

Vijayabhaskar Dronadula

Registered Office

Natco House,

Road No 2 Banjara Hills,

Telangana - 500033

Tel: 91-040-23547532

Website: http://www.natcopharma.co.in

Email: investors@natcopharma.co.in

Registrar Office

12-10-167,

Bharath Nagar,

Hyderbad - 500018

Tel: 91-040-23818475/76/2

Website: www.vccilindia.com

Email: info@vccilindia.com

Summary

Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited. It became a deemed public company with ef...
Read More

Company FAQs

What is the Natco Pharma Ltd share price today?

The Natco Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹884.45 today.

What is the Market Cap of Natco Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Natco Pharma Ltd is ₹15841.37 Cr. as of 27 Jun ‘25

What is the PE and PB ratio of Natco Pharma Ltd?

The PE and PB ratios of Natco Pharma Ltd is 8.55 and 2.16 as of 27 Jun ‘25

What is the 52 Week High and Low of Natco Pharma Ltd?

The 52-week high/low is the highest and lowest price at which a Natco Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Natco Pharma Ltd is ₹726.8 and ₹1639 as of 27 Jun ‘25

What is the CAGR of Natco Pharma Ltd?

Natco Pharma Ltd's CAGR for 5 Years at 6.56%, 3 Years at 10.88%, 1 Year at -26.05%, 6 Month at -36.05%, 3 Month at 6.03% and 1 Month at -0.96%.

What is the shareholding pattern of Natco Pharma Ltd?

The shareholding pattern of Natco Pharma Ltd is as follows:
Promoters - 49.56 %
Institutions - 23.15 %
Public - 27.29 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.